FISPB
BIIB icon

Fideuram - Intesa Sanpaolo Private Banking’s Biogen BIIB Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Sell
15,238
-735
-5% -$141K 0.1% 186
2026
Q1 		$2.93M Sell
15,973
-2,900
-15% -$534K 0.1% 194
2025
Q4 		$3.32M Buy
+18,873
New +$3.08M 0.12% 166

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's BIIB Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking reduced its Biogen (BIIB) stake by 4.6% in Q2 2026, selling an estimated $141K and leaving 15,238 shares worth $3.29M. The position accounts for 0.1% of the portfolio, ranked #186.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.32M in Q4 2025. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 15,238 shares of Biogen worth $3.29M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking sold 735 Biogen shares in Q2 2026, an estimated $141K.
  • Biogen made up 0.1% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #186 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • Fideuram - Intesa Sanpaolo Private Banking's Biogen position peaked at $3.32M in Q4 2025.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.